European Archives - Page 341 of 811 - European Medical Journal

Continue
27th July 2020

EMJ Podcast: 2020 Vision in IBD

This episode provides an overview of the symposium ‘20 20 Vision in IBD’ from ECCO. Listen now for more details
24th July 2020

EMJ Podcast: Managing AF Patients with ACS and/or Undergoing PCI

In this episode Jonathan Sackier chats to Dr Amit Vora from Duke University about the results of the AUGUSTUS trial.
1 Mins
24th July 2020

Credit Card-Sized Tool to Grow Cancer Cells Outside of the Human Body

INVASION and metastasis of tumour cells poses a significant challenge in cancer treatment; in the face of growing concerns, a team at
1 Mins
24th July 2020

Is Immunotherapy Safe for COVID-19 Patients?

COMORBID COVID-19 and cancer is complicated by immunotherapy treatment, which activates an immune system response that may already be overactive
3 Mins
23rd July 2020

Interview: Prof Hamid Rabb

Prof Hamid Rabb   |  Professor of Medicine and Medical Director of the Johns Hopkins Kidney Transplant Program…
2 Mins
23rd July 2020

The Association Between Cystatin C and Arterial Stiffness in Non-Chronic Kidney Disease Patients

Serum cystatin C (cysC) is a protease inhibitor with a low molecular weight, which is produced by all nucleated cells at a constant rate…
July 2020

EMJ Nephrology 8.1 2020

This ejournal contains high quality peer-reviewed articles, a review of the ERA-EDTA Virtual Congress 2020…
12 Mins
23rd July 2020

Review of the European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Virtual Congress 2020

CAPITAL of Lombardy, one of the world’s four fashion capitals, and unparalleled collector of works by Leonardo da Vinci, Michelangelo, and Caravaggio…
1 Mins
23rd July 2020

Digital Education for Patients with Chronic Kidney Disease: The Renal Health Project Experience

Chronic kidney disease (CKD) is a growing problem in many parts of the world, with >700 million people affected.1 One of the main challenges in the…
8 Mins
23rd July 2020

Editor’s Pick: New Aspects of Pathogenesis and Treatment of Membranous Glomerulopathy After the MENTOR Study

Membranous nephropathy (MN) is the major cause of nephrotic syndrome in adults, accounting for 20% of cases with an annual incidence of 1 per 100,000 population.